{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:37:48Z","timestamp":1789115868434,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40265-025-02278-7","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:45:50Z","timestamp":1769849150000},"page":"359-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Potential of Authorised Drugs to be Repurposed for the Treatment of Osteoarthritis: A Scoping Review of Clinical Studies"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-7375","authenticated-orcid":false,"given":"Michelle W. J.","family":"Heijman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia H. M.","family":"van den Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calin D.","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"6","key":"2278_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2217\/thy.10.70","volume":"7","author":"T Uhlig","year":"2010","unstructured":"Uhlig T, Slatkowsky-Christensen B, Moe RH, Kvien TK. The burden of osteoarthritis: the societal and the patient perspective. Ther. 2010;7(6):605\u201319.","journal-title":"Ther"},{"issue":"7","key":"2278_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74(7):1172\u201383. https:\/\/doi.org\/10.1002\/art.42089.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"2278_CR3","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"JD Steinmetz","year":"2023","unstructured":"Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG, et al. Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508\u201322. https:\/\/doi.org\/10.1016\/S2665-9913(23)00163-7.","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"2278_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.joca.2021.05.007","volume":"30","author":"VP Leifer","year":"2022","unstructured":"Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthr Cartil. 2022;30(1):10\u20136. https:\/\/doi.org\/10.1016\/j.joca.2021.05.007.","journal-title":"Osteoarthr Cartil"},{"key":"2278_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p24","volume":"380","author":"G Wood","year":"2023","unstructured":"Wood G, Neilson J, Cottrell E, Hoole SP. Osteoarthritis in people over 16: diagnosis and management\u2014updated summary of NICE guidance. BMJ. 2023;380:24. https:\/\/doi.org\/10.1136\/bmj.p24.","journal-title":"BMJ"},{"key":"2278_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221085952","author":"H Kim","year":"2022","unstructured":"Kim H, Seo J, Lee Y, Park K, Perry TA, Arden NK, et al. The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Ther Adv Musculoskelet Dis. 2022. https:\/\/doi.org\/10.1177\/1759720X221085952.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2278_CR7","unstructured":"US Food and Drug Administration. Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment Guidance for Industry. Silver Spring; 2018."},{"key":"2278_CR8","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.joca.2015.07.001","volume":"23","author":"JY Reginster","year":"2015","unstructured":"Reginster JY, Reiter-Niesert S, Bruy\u00e8re O, Berenbaum F, Brandi ML, Branco J, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthr Cartil. 2015;23:2086\u201393. https:\/\/doi.org\/10.1016\/j.joca.2015.07.001.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"2278_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"key":"2278_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221090297","volume":"14","author":"WM Oo","year":"2022","unstructured":"Oo WM, Hunter DJ. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Ther Adv Musculoskelet Dis. 2022;14:1759720X2210902. https:\/\/doi.org\/10.1177\/1759720X221090297.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"2278_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41584-020-00518-6","volume":"16","author":"A Latourte","year":"2020","unstructured":"Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020;16(12):673\u201388.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"2278_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.joca.2024.05.008","volume":"32","author":"W Kuswanto","year":"2024","unstructured":"Kuswanto W, Baker MC. Repurposing drugs for the treatment of osteoarthritis. Osteoarthr Cartil. 2024;32(8):886\u201395. https:\/\/doi.org\/10.1016\/j.joca.2024.05.008.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"2278_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2278_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","journal-title":"Int J Soc Res Methodol Theory Pract"},{"key":"2278_CR15","unstructured":"Lobbestael G. DedupEndNote (Version 0.9.7e) [Computer software]. 2023. https:\/\/github.com\/globbestael\/DedupEndNote."},{"issue":"2","key":"2278_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s42256-020-00287-7","volume":"3","author":"R van de Schoot","year":"2021","unstructured":"van de Schoot R, de Bruin J, Schram R, Zahedi P, de Boer J, Weijdema F, et al. An open source machine learning framework for efficient and transparent systematic reviews. Nat Mach Intell. 2021;3(2):125\u201333. https:\/\/doi.org\/10.1038\/s42256-020-00287-7.","journal-title":"Nat Mach Intell"},{"key":"2278_CR17","doi-asserted-by":"publisher","unstructured":"Boetje J, Van De Schoot R. The SAFE procedure: a practical stopping heuristic for active learning-based screening in systematic reviews and meta-analyses. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2856011\/v1.","DOI":"10.21203\/rs.3.rs-2856011\/v1"},{"issue":"7","key":"2278_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","volume":"26","author":"D Aitken","year":"2018","unstructured":"Aitken D, Laslett LL, Pan F, Haugen IK, Otahal P, Bellamy N, et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoaRthritis \u2013 the HUMOR trial. Osteoarthr Cartil. 2018;26(7):880\u20137. https:\/\/doi.org\/10.1016\/j.joca.2018.02.899.","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"2278_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","volume":"71","author":"LL Laslett","year":"2012","unstructured":"Laslett LL, Dor\u00e9 DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis. 2012;71(8):1322\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200970.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2278_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","volume":"51","author":"S Ferrero","year":"2021","unstructured":"Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V, et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021;51(4):831\u20138. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.016.","journal-title":"Semin Arthritis Rheum"},{"key":"2278_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.joca.2020.11.002","volume":"29","author":"CR Davis","year":"2021","unstructured":"Davis CR, Ruediger CD, Dyer KA, Lester S, Graf SW, Kroon FPB, et al. Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthr Cartil. 2021;29:208\u201314. https:\/\/doi.org\/10.1016\/j.joca.2020.11.002.","journal-title":"Osteoarthr Cartil"},{"key":"2278_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker M, Conaghan PG, Mindeholm L, Praestgaard J, Solomon DH, Scotti C, et al. Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2020;173:509\u201315. https:\/\/doi.org\/10.7326\/M20-0527.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2278_CR23","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1093\/rheumatology\/keab234","volume":"60","author":"G Nakafero","year":"2021","unstructured":"Nakafero G, Grainge MJ, Valdes AM, Townsend N, Mallen CD, Zhang W, et al. \u03b2-Blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study. Rheumatology (United Kingdom). 2021;60(12):5686\u201396. https:\/\/doi.org\/10.1093\/rheumatology\/keab234.","journal-title":"Rheumatology (United Kingdom)"},{"issue":"3","key":"2278_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41591-024-02822-0","volume":"30","author":"R Wittoek","year":"2024","unstructured":"Wittoek R, Verbruggen G, Vanhaverbeke T, Colman R, Elewaut D. RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nat Med. 2024;30(3):829\u201336. https:\/\/doi.org\/10.1038\/s41591-024-02822-0.","journal-title":"Nat Med"},{"issue":"17","key":"2278_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","volume":"391","author":"H Bliddal","year":"2024","unstructured":"Bliddal H, Bays H, Czernichow S, Udd\u00e9n Hemmingsson J, Hjelmes\u00e6th J, Hoffmann Morville T, et al. Once-weekly semaglutide in persons with obesity and knee osteoarthritis. N Engl J Med. 2024;391(17):1573\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2403664.","journal-title":"N Engl J Med"},{"issue":"3","key":"2278_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.11124\/JBIES-22-00123","volume":"21","author":"D Pollock","year":"2023","unstructured":"Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520\u201332. https:\/\/doi.org\/10.11124\/JBIES-22-00123.","journal-title":"JBI Evid Synth"},{"key":"2278_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.22159\/ajpcr.2018.v11s4.31688","volume":"Special Issue 4","author":"D Praveen","year":"2018","unstructured":"Praveen D, Ranadheer Chowdary P, Rujaswini T, Niventhi A, Elancheziyan K, Vijey Aanandhi M. A prospective observational study on safety and efficacy of hydroxychloroquine against diclofenac in osteoarthritis. Asian J Pharm Clin Res. 2018;Special Issue 4:95\u20137. https:\/\/doi.org\/10.22159\/ajpcr.2018.v11s4.31688.","journal-title":"Asian J Pharm Clin Res"},{"key":"2278_CR28","first-page":"513","volume":"29","author":"S Aran","year":"2011","unstructured":"Aran S, Malekzadeh S, Seifirad S. A double-blind randomised controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee. Clin Exp Rheumatol. 2011;29:513\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2278_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/ajcn\/nqaa328","volume":"113","author":"H Gudbergsen","year":"2021","unstructured":"Gudbergsen H, Overgaard A, Henriksen M, W\u00e6hrens EE, Bliddal H, Christensen R, et al. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial. Am J Clin Nutr. 2021;113(2):314\u201323. https:\/\/doi.org\/10.1093\/ajcn\/nqaa328.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2278_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/ar1716","volume":"7","author":"TD Spector","year":"2005","unstructured":"Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther. 2005;7(3):R625. https:\/\/doi.org\/10.1186\/ar1716.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2278_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.7326\/M17-1430","volume":"168","author":"SR Kingsbury","year":"2018","unstructured":"Kingsbury SR, Tharmanathan P, Keding A, Ronaldson SJ, Grainger A, Wakefield RJ, et al. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis a randomized trial. Ann Intern Med. 2018;168(6):385\u201395. https:\/\/doi.org\/10.7326\/M17-1430.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2278_CR32","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.joca.2016.05.020","volume":"24","author":"NK Arden","year":"2016","unstructured":"Arden NK, Cro S, Sheard S, Dor\u00e9 CJ, Bara A, Tebbs SA, et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. Osteoarthr Cartil. 2016;24(11):1858\u201366. https:\/\/doi.org\/10.1016\/j.joca.2016.05.020.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"2278_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jama.2012.164487","volume":"309","author":"T McAlindon","year":"2013","unstructured":"McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 2013;309(2):155\u201362. https:\/\/doi.org\/10.1001\/jama.2012.164487.","journal-title":"JAMA"},{"issue":"2","key":"2278_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10165-011-0506-8","volume":"22","author":"G Saviola","year":"2012","unstructured":"Saviola G, Abdi-Ali L, Campostrini L, Sacco S, Baiardi P, Manfredi M, et al. Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study. Mod Rheumatol. 2012;22(2):256\u201363. https:\/\/doi.org\/10.1007\/s10165-011-0506-8.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2278_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000441418","volume":"25","author":"K Al-Jarallah","year":"2016","unstructured":"Al-Jarallah K, Shehab D, Abdella N, Al Mohamedy H, Abraham M. Knee osteoarthritis in type 2 diabetes mellitus: does insulin therapy retard osteophyte formation? Med Princ Pract. 2016;25(1):12\u20137. https:\/\/doi.org\/10.1159\/000441418.","journal-title":"Med Princ Pract"},{"issue":"7","key":"2278_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/2230-8210.94254","volume":"16","author":"A Gundgurthi","year":"2012","unstructured":"Gundgurthi A, Kharb S, Dutta M, Pakhetra R, Garg M. Insulin poisoning with suicidal intent. Indian J Endocrinol Metab. 2012;16(7):120. https:\/\/doi.org\/10.4103\/2230-8210.94254.","journal-title":"Indian J Endocrinol Metab"},{"key":"2278_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RHU.0b013e31827cd578","volume":"19","author":"M Nieves Plaza","year":"2013","unstructured":"Nieves Plaza M, Castro-Santana L, Font Y, Mayor A, Vila L. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol. 2013;19:1\u20136. https:\/\/doi.org\/10.1097\/RHU.0b013e31827cd578.","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"2278_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/annrheumdis-2020-219646","volume":"80","author":"P Ballal","year":"2021","unstructured":"Ballal P, Peloquin C, Boer CG, Neogi T. Warfarin use and risk of knee and hip replacements. Ann Rheum Dis. 2021;80(5):605\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219646.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2278_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/annrheumdis-2020-219483","volume":"80","author":"CG Boer","year":"2021","unstructured":"Boer CG, Szilagyi I, Nguyen NL, Neogi T, Meulenbelt I, Ikram MA, et al. Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis. Ann Rheum Dis. 2021;80(5):598\u2013604. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219483.","journal-title":"Ann Rheum Dis"},{"key":"2278_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03562-1","author":"YT Yeh","year":"2020","unstructured":"Yeh YT, Liang CC, Chang CL, Hsu CY, Li PC. Increased risk of knee osteoarthritis in patients using oral N-acetylcysteine: a nationwide cohort study. BMC Musculoskelet Disord. 2020. https:\/\/doi.org\/10.1186\/s12891-020-03562-1.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"2278_CR41","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/art.40483","volume":"70","author":"SM Hussain","year":"2018","unstructured":"Hussain SM, Wang Y, Giles GG, Graves S, Wluka AE, Cicuttini FM. Female reproductive and hormonal factors and incidence of primary total knee arthroplasty due to osteoarthritis. Arthritis Rheumatol. 2018;70(7):1022\u20139. https:\/\/doi.org\/10.1002\/art.40483.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2278_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/17453679708996687","volume":"68","author":"E Ving\u00e5rd","year":"1997","unstructured":"Ving\u00e5rd E, Alfredsson L, Malchau H. Lifestyle factors and hip arthrosis. A case referent study of body mass index, smoking and hormone therapy in 503 Swedish women. Acta Orthop Scand. 1997;68(3):216\u201320. https:\/\/doi.org\/10.3109\/17453679708996687.","journal-title":"Acta Orthop Scand"},{"issue":"5","key":"2278_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jbspin.2017.09.014","volume":"85","author":"F Eymard","year":"2018","unstructured":"Eymard F, Parsons C, Edwards MH, Petit-Dop F, Reginster JY, Bruy\u00e8re O, et al. Statin use and knee osteoarthritis progression: results from a post-hoc analysis of the SEKOIA trial. Jt Bone Spine. 2018;85(5):609\u201314. https:\/\/doi.org\/10.1016\/j.jbspin.2017.09.014.","journal-title":"Jt Bone Spine"},{"issue":"3","key":"2278_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/ard.58.3.151","volume":"58","author":"H Sandmark","year":"1999","unstructured":"Sandmark H, Hogstedt C, Lewold S, Ving\u00e5rd E. Osteoarthrosis of the knee in men and women in association with overweight, smoking, and hormone therapy. Ann Rheum Dis. 1999;58(3):151\u20135. https:\/\/doi.org\/10.1136\/ard.58.3.151.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2278_CR45","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00256-023-04284-w","volume":"52","author":"DJ Hunter","year":"2023","unstructured":"Hunter DJ, Collins JE, Deveza L, Hoffmann SC, Kraus VB. Biomarkers in osteoarthritis: current status and outlook\u2014the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiol. 2023;52(11):2323\u201339. https:\/\/doi.org\/10.1007\/s00256-023-04284-w.","journal-title":"Skeletal Radiol"},{"issue":"1","key":"2278_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semarthrit.2018.12.002","volume":"49","author":"K Flechsenhar","year":"2019","unstructured":"Flechsenhar K, Ried JS, Driban JB, Price LL, McAlindon T. Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: data from the Osteoarthritis Initiative. Semin Arthritis Rheum. 2019;49(1):3\u20138. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.12.002.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"2278_CR47","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.21122","volume":"52","author":"KD Brandt","year":"2005","unstructured":"Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 2005;52(7):2015\u201325. https:\/\/doi.org\/10.1002\/art.21122.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2278_CR48","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"key":"2278_CR49","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"key":"2278_CR50","doi-asserted-by":"publisher","DOI":"10.7326\/M23-0289","author":"MWJ Heijman","year":"2023","unstructured":"Heijman MWJ, Fiolet ATL, Mosterd A, Tijssen JGP, van den Bemt BJF, Schut A, et al. Association of low-dose colchicine with incidence of knee and hip replacements: exploratory analyses from a randomized, controlled, double-blind trial. Ann Intern Med. 2023. https:\/\/doi.org\/10.7326\/M23-0289.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2278_CR51","first-page":"7","volume":"18","author":"A Amirpour","year":"2016","unstructured":"Amirpour A, Mousavi MA, Abolghasemi R, Taziki O, Khoddami Vishteh HR. The effect of colchicine in improving the symptoms of patients with knee osteoarthritis. J Babol Univ Med Sci. 2016;18(11):7\u201313.","journal-title":"J Babol Univ Med Sci"},{"key":"2278_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/life12091297","author":"GO Cioroianu","year":"2022","unstructured":"Cioroianu GO, Florescu A, Mu\u0219etescu AE, Sas TN, Rogoveanu OC. Colchicine versus physical therapy in knee osteoarthritis. Life. 2022. https:\/\/doi.org\/10.3390\/life12091297.","journal-title":"Life"},{"key":"2278_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.10455","volume":"47","author":"SK Das","year":"2002","unstructured":"Das SK, Ramakrishnan S, Mishra K, Srivastava R, Agarwal GG, Singh R, et al. A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report. Arthritis Care Res (Hoboken). 2002;47:280\u20134. https:\/\/doi.org\/10.1002\/art.10455.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2278_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/joca.2002.0516","volume":"10","author":"SK Das","year":"2002","unstructured":"Das SK, Mishra K, Ramakrishnan S, Srivastava R, Agarwal GG, Singh R, et al. A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee. Osteoarthr Cartil. 2002;10:247\u201352. https:\/\/doi.org\/10.1053\/joca.2002.0516.","journal-title":"Osteoarthr Cartil"},{"key":"2278_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00065-6","author":"A D\u00f8ssing","year":"2023","unstructured":"D\u00f8ssing A, Henriksen M, Ellegaard K, Nielsen SM, Stamp LK, M\u00fcller FC, et al. Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2023. https:\/\/doi.org\/10.1016\/S2665-9913(23)00065-6.","journal-title":"Lancet Rheumatol"},{"key":"2278_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.joca.2018.01.026","volume":"26","author":"YY Leung","year":"2018","unstructured":"Leung YY, Haaland B, Huebner JL, Wong SBS, Tjai M, Wang C, et al. Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial. Osteoarthr Cartil. 2018;26:631\u201340.","journal-title":"Osteoarthr Cartil"},{"key":"2278_CR57","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.joca.2018.01.026","volume":"20","author":"S Qaryaqos","year":"2022","unstructured":"Qaryaqos S, Mohammed M, Abdul M. Efficacy of colchicine in the treatment of primary knee osteoarthritis. NeuroQuantology. 2022;20:710\u20139. https:\/\/doi.org\/10.1016\/j.joca.2018.01.026.","journal-title":"NeuroQuantology"},{"issue":"4","key":"2278_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-098096","volume":"15","author":"MWJ Heijman","year":"2025","unstructured":"Heijman MWJ, van den Ende CHM, Cornel JH, Smolders JMH, Schers HJ, Kievit W, et al. Design of a randomised, placebo-controlled, double-blind multicentre study assessing the effect of colchicine on the incidence of knee or hip replacements in symptomatic knee or hip osteoarthritis: the ECHO trial. BMJ Open. 2025;15(4):e098096. https:\/\/doi.org\/10.1136\/bmjopen-2024-098096.","journal-title":"BMJ Open"},{"key":"2278_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2021.100212","author":"JPM Vrouwe","year":"2021","unstructured":"Vrouwe JPM, Burggraaf J, Kloppenburg M, Stuurman FE. Challenges and opportunities of pharmacological interventions for osteoarthritis: a review of current clinical trials and developments. Osteoarthr Cartil Open. 2021. https:\/\/doi.org\/10.1016\/j.ocarto.2021.100212.","journal-title":"Osteoarthr Cartil Open"},{"key":"2278_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020355","author":"MD Brandt","year":"2025","unstructured":"Brandt MD, Malone JB, Kean TJ. Advances and challenges in the pursuit of disease-modifying osteoarthritis drugs: a review of 2010\u20132024 clinical trials. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13020355.","journal-title":"Biomedicines"},{"issue":"9","key":"2278_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41584-024-01126-4","volume":"20","author":"A Mobasheri","year":"2024","unstructured":"Mobasheri A, Loeser R. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development. Nat Rev Rheumatol. 2024;20(9):525\u20136. https:\/\/doi.org\/10.1038\/s41584-024-01126-4.","journal-title":"Nat Rev Rheumatol"},{"key":"2278_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227742","author":"Z Wang","year":"2020","unstructured":"Wang Z, Nayfeh T, Tetzlaff J, O\u2019Blenis P, Murad MH. Error rates of human reviewers during abstract screening in systematic reviews. PLoS\u00a0One. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0227742.","journal-title":"PLoS\u00a0One"},{"key":"2278_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101852","author":"A Mobasheri","year":"2023","unstructured":"Mobasheri A, Thudium CS, Bay-Jensen AC, Maleitzke T, Geissler S, Duda GN, et al. Biomarkers for osteoarthritis: current status and future prospects. Best Pract Res Clin Rheumatol. 2023. https:\/\/doi.org\/10.1016\/j.berh.2023.101852.","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-025-02278-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-025-02278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:35:55Z","timestamp":1772764555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-025-02278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1007\/s40265-025-02278-7","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.P. has received a grant from ZonMw. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study is based on existing and previously published data, which are available for reuse via the published manuscripts and can be found using the search terms and databases provided in Table\n                      \n                      , Supplementary Information\n                      \n                      .","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conception and design: Mi.He., Me.Ha., C.v.d.E., C.P., and B.v.d.B.; analysis and interpretation of the data: Mi.He., Me.Ha., C.v.d.E., C.P., and B.v.d.B.; drafting of the article: Mi.He. and Me.Ha.; and critical revision: C.v.d.E., C.P., and B.v.d.B. All authors have read and approve the final version of the manuscript, and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}